Citation 15844

PETTIT,GR: HERALD,CL: JUDD,GF: BOLLIGER,G: VANELL,LD: LEHTO,E: PASE,CP:. (1978). ANTINEOPLASTIC AGENTS. 52. BAILEYA MULTIRADIATA.. 41(1)

Citation Details

Title	ANTINEOPLASTIC AGENTS. 52. BAILEYA MULTIRADIATA.
Authors	PETTIT,GR: HERALD,CL: JUDD,GF: BOLLIGER,G: VANELL,LD: LEHTO,E: PASE,CP:
Year	1978
Volume	41
Issue	1

Summary

Year: 1978

Journal: Unknown

Organisms and Their Experiments (1)

Baileya multiradiata (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
2	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MULTIRADIATIN	ACTIVE
3	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MULTIRADIATIN	ACTIVE
4	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MULTIRADIATIN	ACTIVE
5	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
6	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
7	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
8	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
9	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
10	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
11	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	ACTIVE
12	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
13	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
14	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
15	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	ACTIVE
16	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
17	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
18	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PLENIRADIN	INACTIVE
19	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROCD SPECTRUM REPORTED FORYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
20	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
21	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
22	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
23	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
24	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
25	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
26	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
27	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
28	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
29	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
30	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
31	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
32	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
33	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	ACTIVE
34	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN C	INACTIVE
35	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROCD SPECTRUM REPORTED FORYIELD IS 50-100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	ACTIVE
36	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	ACTIVE
37	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
38	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
39	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
40	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
41	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
42	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
43	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
44	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
45	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
46	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	ACTIVE
47	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	INACTIVE
48	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FASTIGILIN B	ACTIVE
49	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROCD SPECTRUM REPORTED FORYIELD IS LESS THAN 50 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BAILEYIN	ACTIVE
50	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BAILEYIN	INACTIVE
51	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BAILEYIN	INACTIVE
52	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BAILEYIN	INACTIVE
53	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROCD SPECTRUM REPORTED FORYIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	ACTIVE
54	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	ACTIVE
55	CYTOTOXIC ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	ACTIVE
56	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
57	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
58	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
59	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
60	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
61	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
62	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	INACTIVE
63	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	ACTIVE
64	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	ACTIVE
65	ANTITUMOR ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RADIATIN	ACTIVE

Citation 15844

Citation Details

Summary

Organisms and Their Experiments (1)

Baileya multiradiata (ASTERACEAE)

Show SPARQL Queries (1)

Query 1